PMID: 2492646Feb 1, 1989Paper

Valproic acid hepatic fatalities. II. US experience since 1984

Neurology
F E DreifussJ E Maxwell

Abstract

We have analyzed the usage pattern of valproate and the associated hepatic fatalities that have been reported in the 2 years since our first study evaluating US experience during the period 1978-1984. In this follow-up study (1985-1986), we have observed a nearly fivefold decrease in the incidence of hepatic fatality during a time when the overall use of valproate has increased significantly. The dramatically decreased incidence, from 0.93 per 10,000 (1/10,000) in 1978-1984 to 0.20 per 10,000 (1/49,000) in 1985-1986 appears to be due to changes in the prescribing patterns of physicians, prompted by greater awareness of low-risk versus high-risk patients. More patients are receiving valproate as monotherapy, considerably more low-risk patients are being treated with valproate, and fewer high-risk patients (0 to 2 years old) are being treated with valproate. During 1985-1986, no hepatic fatalities were reported in any patients above the age of 10 years, regardless of whether valproate was administered as monotherapy or polytherapy. The altered exposure pattern, with an increased use of monotherapy, appears to have had a positive impact on the number of hepatic fatalities (four among 198,000 patients treated during 1985-1986) and ...Continue Reading

Citations

Dec 1, 1992·Annals of Neurology·A R BickneseW E Dodson
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·F Pisani
Dec 12, 2007·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Abhishek Katiyar, Cynthia Aaron
Sep 14, 2001·European Journal of Drug Metabolism and Pharmacokinetics·U KreherF Wien
Apr 9, 2008·Journal of Inherited Metabolic Disease·M F B SilvaI Tavares de Almeida
Jan 1, 1995·Pharmacology & Therapeutics·B Fromenty, D Pessayre
Jan 1, 1995·Pharmacology & Therapeutics·B K ParkN R Kitteringham
May 14, 2005·Free Radical Biology & Medicine·Vincent TongFrank S Abbott
Aug 26, 1998·The American Journal of Medicine·K G Tolman
Aug 1, 1993·The Journal of Pediatrics·J V MurphyC Hodge
Mar 1, 1990·The Journal of Pediatrics·A T BergJ M Leventhal
Apr 18, 2003·Pediatric Neurology·Nancy L Grauso-EbyGary N McAbee
Feb 1, 1997·Pediatric Neurology·P R NjølstadP E Waaler
May 22, 2003·Free Radical Biology & Medicine·Vincent TongFrank S Abbott
Aug 15, 2000·Epilepsy Research·E PeruccaT Tomson
Oct 24, 2001·Epilepsy Research·S Arroyo, A de la Morena
Mar 1, 2003·Epilepsy & Behavior : E&B·John M. Pellock
Jan 18, 1996·The New England Journal of Medicine·M J Brodie, M A Dichter
Nov 1, 1992·British Journal of Clinical Pharmacology·B K ParkN R Kitteringham
Oct 1, 1996·British Journal of Clinical Pharmacology·I ChoonaraA Nunn
Jan 1, 1992·Epilepsia·W KreuzI Scharrer
Jan 1, 1993·Epilepsia·J J AsconapéW Mirza
Jan 1, 1993·Epilepsia·V Gross-Tsur, S Shinnar
Sep 1, 1994·Epilepsia·M A VanceK G Tolman
Jan 1, 1995·Epilepsia·B F Bourgeois
May 21, 1998·Epilepsia·R GuerriniP Genton
Mar 28, 2007·Epilepsia·Gaetano ZaccaraEmilio Perucca
Jan 1, 1992·Acta Neurologica Scandinavica. Supplementum·B F Bourgeois
Sep 18, 2008·International Journal of Clinical Practice·S Sathasivam, A Nicolson
Oct 1, 1991·Archives of Disease in Childhood·N V O'Donohoe
Dec 11, 2007·Canadian Journal of Physiology and Pharmacology·Andrew M NumaThomas K H Chang
Aug 28, 2010·Journal of Biomedicine & Biotechnology·Sébastien ChateauvieuxMarc Diederich
Apr 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Ewa PronickaGrzegorz Wegrzyn
Dec 4, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Hugo M NeelsWilly E Lambert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.